Predicting benefit from imatinib: Are we close?

Producción científica: Comment/debate › revisión exhaustiva

ASJC Scopus subject areas

@article{d0ab1916d09a4e2ebbf7fa80c11a9a06,

title = "Predicting benefit from imatinib: Are we close?",

author = "Gandhi, \{Mitul D.\} and Kaklamani, \{Virginia G.\}",

year = "2014",

month = nov,

day = "1",

doi = "10.3109/10428194.2014.909041",

language = "English (US)",

volume = "55",

pages = "2421--2422",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

number = "11",

}

TY - JOUR

T1 - Predicting benefit from imatinib

T2 - Are we close?

AU - Gandhi, Mitul D.

AU - Kaklamani, Virginia G.

PY - 2014/11/1

Y1 - 2014/11/1

UR - https://www.scopus.com/pages/publications/84912127521

UR - https://www.scopus.com/pages/publications/84912127521#tab=citedBy

U2 - 10.3109/10428194.2014.909041

DO - 10.3109/10428194.2014.909041

M3 - Comment/debate

C2 - 24684225

AN - SCOPUS:84912127521

SN - 1042-8194

VL - 55

SP - 2421

EP - 2422

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 11

ER -